Vor Biopharma Inc.
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hemato…
Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Vor Biopharma Inc. (VOR) to it's peer group.
Peer Group
NUVL ACLX CGEM STTK FHTX KYMR VTYX DAWN ACET EWTX BOLT DSGN GLUE ERAS TALS NRIX LYRA THRX
Compare Together
Loading...